Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-427-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Public literature, no detailed study report available
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Distribution and Excretion of BisGMA in Guinea Pigs
- Author:
- Reichl
- Year:
- 2 008
- Bibliographic source:
- J. Dent. Res. 87 (4): 378-380, 2008
- Reference Type:
- publication
- Title:
- Distribution and Excretion of BisGMA in Guinea Pigs, Appendix
- Author:
- Reichl
- Year:
- 2 008
- Bibliographic source:
- J. Dent. Res. 87 (4): 378-380, 2008, i-v
Materials and methods
- Objective of study:
- other: distribution and excretion
- Principles of method if other than guideline:
- The uptake, distribution and excretion of radio labeled BisGMA applied via gastric and intravenous administration were examined in vivo in guinea pigs.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- bisGMA
- IUPAC Name:
- bisGMA
- Details on test material:
- bisGMA is the main constituent of Small Vinyl Ester and Modified Small Vinyl Ester.
B[14C]BisGMA was purchased from Perkin Elmer.
Constituent 1
- Radiolabelling:
- yes
- Remarks:
- 14-C
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Adult male guinea pigs (400 g). Each animal was put into a separate metabolic cage 3 days before the start of the study, and food was removed 12 hours before the start of the treatment. No details were provided on the environmental conditions.
Administration / exposure
- Route of administration:
- other: gavage and intravenous
- Vehicle:
- DMSO
- Duration and frequency of treatment / exposure:
- Single exposure.
- Details on study design:
- In situ experiment:
Guinea pigs were randomized and allotted to 3 groups of 4 animals each. The ductus cysticus was ligated, and a cannula was placed in the bile duct. A 1 ml/kg quantity of BisGMA, dissolved in DMSO (final concentration DMSO 1%) was injected via the jugular vein (0.02 µmol/kg bw, labeled with a tracer dose of [14C]BisGMA (0.3 kBq/g bw). Control animals received either 0.9% NaCl solution or DMSO (final concentration 1% DMSO in 0.9% NaCl).
In vivo Experiments
Twelve guinea pigs were allotted to 3 groups of 4 animals each. Each animal received BisGMA (0.02 µmol/kg bw, dissolved in 1% DMSO), labeled with a tracer dose of [14CBisGMA (0.3 kBq/g bw), via gavage. Control animals received either 0.9% NaCl solution or DMSO (final concentration 1% DMSO in 0.9% NaCl). The volume for the application through the gastric tube was 4 ml/kg.
A second set of 12 guinea pigs was treated as described above, with the addition, that each animal was kept in a closed chamber with controlled air flow. - Details on dosing and sampling:
- In situ experiment:
Blood was withdrawn form the carotid artery. Samples of the bile (0.4 ml) and blood (0.2 ml) were taken every 10 minutes. The experimental period was 60 minutes. The organs and their contents were immediately removed and their [14C]-radioactivity measured.
In vivo experiment:
Feces and urine were collected at 1, 2, 4, 6, 8, 12, and 24 hours after [14C]BisGMA administration, and the [14C]-radioactivity was measured. Twenty four hours after the beginning of the experiment, the animals were killed in ether. The organs and their contents were immediately removed and their [14C]-radioactivity measured.
From the animals kept in the closed chamber, the exhaled air was captured during the 24-hour experimental period, in addition to the collection of urine and feces for 24 hours and analysis of organs.
Guinea pig organs:
For all experiments the following organs were taken: liver, kidney, blood, skin, brain, heart, spleen, lung, muscle, testes, eyes, bone, nerve tissue, spinal cord, wall of stomach, content of stomach, wall and content of ileum and jejunum, wall and content of colon, wall and content of caecum, wall of gall bladder and fat tissue. Organs were immediately washed with 2 x 10 ml distilled H2O, the wash-water was saved, and then the tissues were weighed and homogenized.
Determination of Radioactivity:
Tissues were dissolved in TEAH (20%) in aqueous solution with Omni-Szintisol. Radioactivity was determined with a liquid scintillation counter. - Statistics:
- Data were presented as means +/- SEM. Statisticall significance of the differences between the experimental groups was determined by the Bonferroni-Holm t test.
Results and discussion
Any other information on results incl. tables
During the first hour after [14C]BisGMA intravenous injection, about 12% of the radio label was excreted via the bile, and about 50% reamined in the tissues at 1 hour, the time the guinea pigs were killed. Radio label was rapidly removed from the blood. No significant change in bile flux was observed during the 60 minutes in guinea pigs that had received radio labeled BisGMA, when compared to controls. One hour after intravenous injection, radio activity found in the l ungs was about 8% and in the brain 1% of the administered radio label (per gram organ). Radio activity in other organs was lower than 0.4% (per gram organ).
In the total blood, radio activity was foudn to be about 4% of the dose, 10 minutes after intravenous administration. From these data a plasma half-life period for BisGMA can be calculated that must be lower than 10 minutes.
In vivo experiments:
Duirng the first 24 hours after radio labelled BisGMA oral gavage, guinea pigs exhaled 14CO2 equivalent to about 65% fo the radio label administered. About 7% of the radiolabel was excreted via urine, 5% was excreted via feces, and about 6% remained in the tissues at 24 hours, the time the animals were killed. The total recovery was about 85% of the radio label administered. During the 24 hours, the amount of feces and urine excreted was not changed when compared to control animals. Radio label in organs ans walls and/or contents of organs in guinea pigs at 24 hours, was found in lungs about 0.035% and in the brain about 0.002% of the administered radio label.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
